Braxia Scientific

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. Braxia Scientific Corp. is headquartered in Toronto, Ontario.

Our mission is to continue our exploration of the natural world and create technology that makes a difference in the world and in people’s lives.

Our vision is to be the leading company in advanced research and to explore the boundless potential of technology to help better the world and people’s lives.

Braxia Scientific has been awarded numerous awards, including the Research and Development Award from the National Science Foundation, the Innovation Award from the World Technology Network, and the Global Technology Innovation Award from the International Society for Technology in Education.